Literature DB >> 23828933

Immunology. Making macrophages eat cancer.

Michael H Kershaw1, Mark J Smyth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23828933     DOI： 10.1126/science.1241716

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  12 in total

1.  HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells.

Authors:  Huimin Zhang; Haiquan Lu; Lisha Xiang; John W Bullen; Chuanzhao Zhang; Debangshu Samanta; Daniele M Gilkes; Jianjun He; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-28       Impact factor: 11.205

2.  Chemotherapy induces enrichment of CD47+/CD73+/PDL1+ immune evasive triple-negative breast cancer cells.

Authors:  Debangshu Samanta; Youngrok Park; Xuhao Ni; Huili Li; Cynthia A Zahnow; Edward Gabrielson; Fan Pan; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-24       Impact factor: 11.205

Review 3.  CD47 signaling pathways controlling cellular differentiation and responses to stress.

Authors:  David R Soto-Pantoja; Sukhbir Kaur; David D Roberts
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-02-24       Impact factor: 8.250

Review 4.  Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy.

Authors:  Bin Ji; Minjie Wei; Bin Yang
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

5.  Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.

Authors:  Xiao-Hua Jia; Guo-Wei Feng; Zhong-Liang Wang; Yang Du; Chen Shen; Hui Hui; Dong Peng; Zong-Jin Li; De-Ling Kong; Jie Tian
Journal:  Oncotarget       Date:  2016-04-12

6.  A rapid, automated surface protein profiling of single circulating exosomes in human blood.

Authors:  Golam Kibria; Erika K Ramos; Katelyn E Lee; Sarah Bedoyan; Simo Huang; Ravand Samaeekia; Jaffre J Athman; Clifford V Harding; Jan Lötvall; Lyndsay Harris; Cheryl L Thompson; Huiping Liu
Journal:  Sci Rep       Date:  2016-11-07       Impact factor: 4.379

7.  A fully human anti-CD47 blocking antibody with therapeutic potential for cancer.

Authors:  Dadi Zeng; Qiang Sun; Ang Chen; Jiangfeng Fan; Xiaopeng Yang; Lei Xu; Peng Du; Weiyi Qiu; Weicai Zhang; Shuang Wang; Zhiwei Sun
Journal:  Oncotarget       Date:  2016-12-13

8.  Third-Generation Anti-CD47-Specific CAR-T Cells Effectively Kill Cancer Cells and Reduce the Genes Expression in Lung Cancer Cell Metastasis.

Authors:  Huyen Thi La; Dao Bich Thi Tran; Hai Manh Tran; Linh Trong Nguyen
Journal:  J Immunol Res       Date:  2021-06-02       Impact factor: 4.818

9.  Activating Macrophage-Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles.

Authors:  Lang Rao; Shu-Kun Zhao; Churan Wen; Rui Tian; Lisen Lin; Bo Cai; Yue Sun; Fei Kang; Zhen Yang; Liangcan He; Jing Mu; Qian-Fang Meng; Guangyu Yao; Ni Xie; Xiaoyuan Chen
Journal:  Adv Mater       Date:  2020-10-21       Impact factor: 32.086

10.  Relationship between immunohistochemical staining extent of CD47 and histopathologic features of bladder tumor.

Authors:  Erkan Olcucuoglu; Mehmet Emin Sirin; Gulden Aydog; Eymen Gazel; Sedat Tastemur; Oner Odabas
Journal:  Cent European J Urol       Date:  2017-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.